|
|
|
|
 |
 |
 |
|
 |
|
|
Past Bulletins and News Flashes - 2002 and prior |
|
Receipt date changed for RFA for Breast Cancer and the Environment Research CentersThe deadline for receipt of applications submitted in response to the Request for Applications (RFA) for Breast Cancer and the Environment Research Centers has been extended to April 14, 2003. The date had been February 11. The date for receipt of letters of intent is changed to March 14. This RFA is cosponsored by the National Institute of Environmental Health Sciences (NIEHS) and the National Cancer Institute (NCI). Notice, NOT-ES-03-006,
of the change appeared in the NIH Guide for Grants and You also may be interested in viewing information from a pre-application meeting that was held in mid-December. Visit NIEHS' Web site to access the print materials and video. The RFA, ES-03-001, appeared in the NIH Guide, release date November 11, 2002. Please direct inquiries about the RFA to NIEHS Program Director Gwen Collman, Ph.D., or NCI Program Director Kumiko Iwamoto, M.D., Dr.P.H. The staff of the Epidemiology and Genetics Research Program wish you
a happy
We let you know recently about a Request for Applications (RFA)
to establish breast cancer and the environment centers that is being cosponsored
by the National Institute of Environmental Health Sciences (NIEHS) and
the National Cancer Institute (NCI). A pre-application meeting is set
for Friday, December 13, for investigators who are planning to submit
applications in response to the RFA. Notice of the meeting, NOT-ES-03-004,
appears in the NIH Guide for Grants and Contracts. Please refer to the Notice for further information about the meeting, which will be held in Research Triangle Park, N.C., including availability of a real-time Internet simulcast and names of contacts. On-site attendees must register on-line by Wednesday, December 11, and NIEHS would appreciate hearing in advance about interest among others in the simulcast. Letters of intent for the RFA are due December 31, and applications are due February 11, 2003. New Request for Applications and Other Funding Opportunities:
Trapido Appointed Associate Director of Epidemiology and Genetics Research ProgramThe National Cancer Institute (NCI) has appointed Edward Trapido, Sc.D. (photo), of the University of Miami School of Medicine, to be the new Associate Director of the Epidemiology and Genetics Research Program (EGRP), Division of Cancer Control and Population Sciences (DCCPS). Trapido will plan, direct, and manage NCI's extramural epidemiology and genetic epidemiology research program, which supports more than 400 research grants and cooperative agreements totaling $280 million. He will join NCI in September. As Associate Director of EGRP, Trapido will have many opportunities to shape the direction of cancer epidemiology and genetics. He will oversee and further development of the Cancer Family Registries, Cancer Genetics Network, and the new Cohort Consortium, which are all multi-institutional infrastructures supporting modern cancer epidemiology. Among his challenges will be to stimulate and support research on gene-gene and gene-environment interactions, and to facilitate the development of research consortia able to conduct studies that require very large populations. He also will work to further new NCI initiatives to identify social determinants of cancer outcomes and cancer-related health disparities. Trapido is Professor and Vice Chair of the Department of Epidemiology and Public Health, University of Miami School of Medicine. He also is Associate Director for Cancer Prevention and Control at the Sylvester Comprehensive Cancer Center, and directs the M.P.H. and Ph.D. Epidemiology Teaching Programs. Principal investigator of several major cancer control research and education programs, Trapido directs the NCI Cancer Information Service, Florida Cancer Data System, Florida Comprehensive Cancer Control Initiative, and the Southeast Region of Redes En Action, which focuses on Hispanic cancer prevention and control activities. He also is Director of the Tobacco Research and Evaluation Coordinating Center and special consultant to the Florida Tobacco Pilot Program, which has received nationwide acclaim for reducing teenage smoking. Before joining the University of Miami as an epidemiologist in 1984, Trapido was a staff fellow for three years in NCI’s intramural epidemiology program, which is the predecessor of today’s Division of Cancer Epidemiology and Genetics (DCEG). From 1977 to 1981, he was a research fellow and then a research associate in the Department of Epidemiology, Harvard School of Public Health. He earned an M.S.P.H. in parasitology from the University of North Carolina at Chapel Hill in 1974, and holds Sc.M and Sc.D. degrees from Harvard University School of Public Health in 1981. He is a member of the American College of Epidemiology. Until Trapido’s arrival, Deborah (Debbie) Winn, Ph.D., will continue
to provide outstanding leadership as Acting Associate Director of EGRP.
Cancer Genetics Network: A Resource for Research on Genetic Basis of Human Cancer SusceptibilityThe Cancer Genetics Network (CGN) is a resource available to support
research on the genetic basis of human cancer susceptibility, the integration
of this information into medical practice, and on the psychosocial, ethical,
legal, and public health issues associated with human The CGN's interests include:
The growing database has information on 13,000 individuals (12,000 families) with cancer and/or a family history of cancer. Visit the CGN Web site at http://epi.grants.cancer.gov/CGN for more information about the enrollees. Investigators who are interested in accessing the data or including registry enrollees in ongoing or proposed studies should prepare a 1-page description of their research to include the specific aims and an explanation of the role of CGN enrollees in the research. Research funding is not provided. Priority is given to funded investigators or to those who are planning to submit applications for National Institutes of Health grants. Direct proposals and inquiries to:
Invitation to Comment on NIH Draft Statement on Sharing Research DataThe deadline for submitting comments about the National Institutes of Health's (NIH) draft statement on sharing of research data is June 1, 2002. NIH is developing a statement on data sharing that expects and supports the timely release and sharing of final research data from NIH-supported studies for use by other researchers. Investigators submitting an NIH application will be required to include a plan for data sharing or to state why data sharing is not possible. This statement will apply to extramural scientists seeking grants, cooperative agreements, and contracts as well as intramural investigators. Institutions and individuals are invited to comment on the draft policy. View additional information. Comments must be received no later than June 1, 2002, and should be sent to:
Following consideration of public comments and appropriate revisions, the new policy is expected to be announced on August 1, 2002, with a proposed effective date of January 1, 2003. The announcement on the draft statement appeared in the NIH GUIDE FOR GRANTS AND CONTRACTS, March 1, 2002.
Myriad Genetics and NCI Renew Agreement on BRCA Gene Research TestingMyriad Genetics, Inc., and the National Cancer Institute (NCI) have renewed their agreement in which the company will provide testing of the BRCA1 and BRCA2 genes at a reduced cost as a service to all National Institutes of Health (NIH) scientists and grantees. The agreement greatly reduces the cost of sequencing these genes in research protocols, allowing scientists to more aggressively pursue their investigations of these important cancer susceptibility genes. It applies to genetic testing for research purposes only, not the delivery of health care services to patients. The agreement makes it possible for researchers to obtain high-quality mutational analysis for research purposes at affordable prices. Recent NCI Publications ReleasedThe National Cancer Institute (NCI) recently released some publications that may be of interest:
Important Message to InvestigatorsOur Division has an important announcement about strict enforcement of the lead time for requesting prior acceptance of unsolicited applications of more than $500,000 in direct costs per year. NIH requires that grant applicants with a requested budget exceeding $500,000 in direct costs in any year contact the appropriate program staff member at least 6 weeks in advance of submitting the grant to the Center for Scientific Review (CSR) for peer review. If the requested dollar amount is greater than $1.5 million in direct costs in any year, then approval must be sought 8 weeks prior to submitting the grant to CSR for review. Please refer to the complete text of the announcement for more very important specifics. New NIH Incoming Mail Address RequirementsThe announcement also explains that grant applications for cohort studies over $500,000 in direct costs in any year must be submitted in response to NCI's Program Announcement for "Cohort Studies in Cancer Epidemiology" (PAS-02-009). The PAS was issued this past summer. On a different note, NIH has new requirements for accepting incoming mail. Refer to the Notice for information about specific zip codes to use. Be especially aware that applications and other deliveries to CSR now must come either via courier delivery or the U.S. Postal Service. Applications delivered by individuals to CSR will no longer be accepted. (NOT-OD-02-012) Our apologies if you've received more than one copy of this communication.
We merged several address lists to send this message. Although the Listserv
deleted duplicates, if we had more than one e-mail address for you, or
had your name recorded in different ways (e.g., with and without middle
initial), you may have received more than one message. We'll try to resolve
the problem for future mailings, if you'll contact Ms. Linda Anderson
and let her know the particulars about how your e-mails were addressed
(E-mail: andersol2@mail.nih.gov;
telephone: 301-435-4906).
Andrew von Eschenbach Named Director of NCIPresident Bush announced today that Andrew C. von Eschenbach, M.D., will head the National Cancer Institute (NCI) at the National Institutes of Health (NIH) in Bethesda, Md.
Policy Updated About Acceptance of Applications Exceeding $500,000 Per YearThe National Institutes of Health (NIH) is updating its policy on the acceptance of applications requesting direct costs of $500,000 or more for any one year. Effective with the January 1, 2002 receipt dates, applicants must seek agreement to accept assignment from Institute/Center staff at least 6 weeks prior to the anticipated submission of any application requesting $500,000 or more in direct costs for any year. A Notice (NOT OD 02 004) appeared in the NIH Guide for Grants and Contracts, release date: October 16, 2001. Program Announcement Issued on Cohort Studies in Cancer EpidemiologyA new Program Announcement (PA) on Cohort Studies in Cancer Epidemiology (PAS 02 009) is published in the NIH Guide for Grants and Contracts, release date: October 11, 2001.
Deadline Extended to Aug. 30 for Supplements for Dissemination of Promising Cancer Control InterventionsThe Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute (NCI), has extended the deadline to August 30, 2001, for applications received in response to a letter Request for Applications (RFA) for supplemental support for dissemination of promising cancer control interventions. The announcement also has been amended to permit submissions of supplemental applications within the last six months of the last year (including an unfunded extension year/no cost extension) of a currently active NCI intervention research R01, P01, P50, U01, or U19 award. Applications must be active (either funded or in an unfunded extension). Access at the Division of Cancer Control and Population Sciences' Web site :
Message to Potential Applicants and Grantees About Cost Control MeasuresDr. Barbara Rimer, Director, Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute (NCI), writes in a message to potential grant applicants and grantees about Institute cost control measures and reasons for them. She also mentions plans to issue soon a Program Announcement for Cohort Studies in Cancer Epidemiology. Dr. Rimer's message is posted now on the Division's Web site. Deadline Extended to Apply for NCI Associate Director, Epidemiology and Genetics Research ProgramThe deadline for receipt of applications for Associate Director of the Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute (NCI), has been extended to July 15, 2001. The Division is seeking a visionary, experienced senior scientist to lead NCI’s extramural program in cancer epidemiology and genetics. Candidates should be recognized national experts in epidemiology with demonstrated leadership in the development and management of large, diverse interdisciplinary research programs. The Associate Director plays a vital role in the success of a complex research program that is central to the NCI mission and has substantial international visibility. For more information on the position and where to submit a letter of interest and C.V., access http://epi.grants.cancer.gov/AD.html.
EGRP's offices moved, and we're now united in Executive Plaza North, 6130 Executive Boulevard, Bethesda, Md. Our telephone numbers have not changed. The EGRP Office of the Director has a new fax number, but the fax numbers for the Analytic Epidemiology and Genetics Research Branch (AERB) and Clinical and Genetic Epidemiology Research Branch (CGERB) remain unchanged. Our e-mail addresses continue to work, but the National Institutes of Health (NIH) recently changed to a new system, and we urge you to update your address book with our new addresses. Some e-mail messages have failed to arrive, and we think the system change is responsible. Refer to Staff Contacts for contact information for individual staff members.
|
|
Search | Help | Contact Us | Accessibility |
News
Flash, December 31, 2002